Davis D - Search Results

1

Synthesis of a trimeric gp120 epitope mimic conjugated to a T-helper peptide to improve antigenicity.

Schellinger JG, Danan-Leon LM, Hoch JA, Kassa A, Srivastava I, Davis D, Gervay-Hague J. Schellinger JG, et al. Among authors: davis d. J Am Chem Soc. 2011 Mar 16;133(10):3230-3. doi: 10.1021/ja1083915. Epub 2011 Feb 22. J Am Chem Soc. 2011. PMID: 21341746 Free PMC article.

2

Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.

Bogers WMJM, Barnett SW, Oostermeijer H, Nieuwenhuis IG, Beenhakker N, Mortier D, Mooij P, Koopman G, Remarque E, Martin G, Lai RP, Dey AK, Sun Y, Burke B, Ferrari G, Montefiori D, Martin L, Davis D, Srivastava I, Heeney JL. Bogers WMJM, et al. Among authors: davis d. J Virol. 2017 Sep 12;91(19):e00811-17. doi: 10.1128/JVI.00811-17. Print 2017 Oct 1. J Virol. 2017. PMID: 28701402 Free PMC article.

3

Systemic neutralizing antibodies induced by long interval mucosally primed systemically boosted immunization correlate with protection from mucosal SHIV challenge.

Bogers WM, Davis D, Baak I, Kan E, Hofman S, Sun Y, Mortier D, Lian Y, Oostermeijer H, Fagrouch Z, Dubbes R, van der Maas M, Mooij P, Koopman G, Verschoor E, Langedijk JP, Zhao J, Brocca-Cofano E, Robert-Guroff M, Srivastava I, Barnett S, Heeney JL. Bogers WM, et al. Among authors: davis d. Virology. 2008 Dec 20;382(2):217-25. doi: 10.1016/j.virol.2008.09.016. Epub 2008 Oct 22. Virology. 2008. PMID: 18947849 Free PMC article.

4

Neutralization of primary HIV-1 SF13 can be detected in extended incubation phase assays with sera from monkeys immunized with recombinant HIV-1 SF2 gp120.

Davis D, Donners H, Willems B, Lövgren-Bengtsson K, Akerblom L, Vanham G, Barnett S, Morein B, Heeney JL, van der Groen G. Davis D, et al. Vaccine. 2004 Jan 26;22(5-6):747-54. doi: 10.1016/j.vaccine.2003.08.031. Vaccine. 2004. PMID: 14741168

5

Antibodies raised to short synthetic peptides with sequences derived from HIV-1 SF2 gp120 can both neutralize and enhance HIV-1 SF13: a later variant isolated from the same host.

Davis D, Trischmann H, Stephens DM, Lachmann PJ. Davis D, et al. J Med Virol. 2001 Jul;64(3):207-16. doi: 10.1002/jmv.1038. J Med Virol. 2001. PMID: 11424106

6

A recombinant prime, peptide boost vaccination strategy can focus the immune response on to more than one epitope even though these may not be immunodominant in the complex immunogen.

Davis D, Morein B, Akerblom L, Lövgren-Bengtsson K, van Gils ME, Bogers WM, Teeuwsen VJ, Heeney JL. Davis D, et al. Vaccine. 1997 Oct;15(15):1661-9. doi: 10.1016/s0264-410x(97)00084-4. Vaccine. 1997. PMID: 9364697

7

Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals.

Corti D, Langedijk JP, Hinz A, Seaman MS, Vanzetta F, Fernandez-Rodriguez BM, Silacci C, Pinna D, Jarrossay D, Balla-Jhagjhoorsingh S, Willems B, Zekveld MJ, Dreja H, O'Sullivan E, Pade C, Orkin C, Jeffs SA, Montefiori DC, Davis D, Weissenhorn W, McKnight A, Heeney JL, Sallusto F, Sattentau QJ, Weiss RA, Lanzavecchia A. Corti D, et al. Among authors: davis d. PLoS One. 2010 Jan 20;5(1):e8805. doi: 10.1371/journal.pone.0008805. PLoS One. 2010. PMID: 20098712 Free PMC article.

8

Protection in macaques immunized with HIV-1 candidate vaccines can be predicted using the kinetics of their neutralizing antibodies.

Davis D, Koornstra W, Mortier D, Fagrouch Z, Verschoor EJ, Heeney JL, Bogers WM. Davis D, et al. PLoS One. 2011;6(12):e28974. doi: 10.1371/journal.pone.0028974. Epub 2011 Dec 28. PLoS One. 2011. PMID: 22216149 Free PMC article.

9

Antisera raised against the second variable region of the external envelope glycoprotein of human immunodeficiency virus type 1 cross-neutralize and show an increased neutralization index when they act together with antisera to the V3 neutralization epitope.

Davis D, Stephens DM, Carne CA, Lachmann PJ. Davis D, et al. J Gen Virol. 1993 Dec;74 ( Pt 12):2609-17. doi: 10.1099/0022-1317-74-12-2609. J Gen Virol. 1993. PMID: 7506300

10

Antibodies are produced to the variable regions of the external envelope glycoprotein of human immunodeficiency virus type 1 in chimpanzees infected with the virus and baboons immunized with a candidate recombinant vaccine.

Stephens DM, Eichberg JW, Haigwood NL, Steimer KS, Davis D, Lachmann PJ. Stephens DM, et al. Among authors: davis d. J Gen Virol. 1992 May;73 ( Pt 5):1099-106. doi: 10.1099/0022-1317-73-5-1099. J Gen Virol. 1992. PMID: 1375277

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,251 results

Search Page

Filters